Evaluation and Treatment of Cognitive-Linguistic Deficits in Liver Disease Patients in the Acute Rehabilitative Phase Liver disease, which can range from mild liver dysfunction to End-Stage Liver Disease (ESLD), is a condition that may have potentially significant implications for cognitive-linguistic function and an individual's ability to participate in activities of daily living (ADLs). This article will outline the multiple, complex, and often interrelated factors that ... Article
Article  |   April 01, 2015
Evaluation and Treatment of Cognitive-Linguistic Deficits in Liver Disease Patients in the Acute Rehabilitative Phase
Author Affiliations & Notes
  • Kara Maharay
    Rehabilitation Medicine, Thomas Jefferson University Hospital, Philadelphia, PA
  • Kelly Salmon
    Rehabilitation Medicine, Thomas Jefferson University Hospital, Philadelphia, PA
  • Financial Disclosure: Kara Maharay is a speech-language pathologist at Thomas Jefferson University Hospital. Kelly Salmon is a speech-language pathologist at Thomas Jefferson University Hospital.
    Financial Disclosure: Kara Maharay is a speech-language pathologist at Thomas Jefferson University Hospital. Kelly Salmon is a speech-language pathologist at Thomas Jefferson University Hospital.×
  • Nonfinancial Disclosure: Kara Maharay has no nonfinancial interests related to the content of this article. Kelly Salmon has no nonfinancial interests related to the content of this article.
    Nonfinancial Disclosure: Kara Maharay has no nonfinancial interests related to the content of this article. Kelly Salmon has no nonfinancial interests related to the content of this article.×
Article Information
Speech, Voice & Prosodic Disorders / Language Disorders / Attention, Memory & Executive Functions / Articles
Article   |   April 01, 2015
Evaluation and Treatment of Cognitive-Linguistic Deficits in Liver Disease Patients in the Acute Rehabilitative Phase
SIG 2 Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders, April 2015, Vol. 25, 78-88. doi:10.1044/nnsld25.2.78
History: Received December 22, 2014 , Revised February 26, 2015 , Accepted March 11, 2015
SIG 2 Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders, April 2015, Vol. 25, 78-88. doi:10.1044/nnsld25.2.78
History: Received December 22, 2014; Revised February 26, 2015; Accepted March 11, 2015

Liver disease, which can range from mild liver dysfunction to End-Stage Liver Disease (ESLD), is a condition that may have potentially significant implications for cognitive-linguistic function and an individual's ability to participate in activities of daily living (ADLs). This article will outline the multiple, complex, and often interrelated factors that are present in this patient population and contributors to cognitive dysfunction. Pharmacological regimens specific to management of liver disease and their potential to cause cognitive-linguistic dysfunction are discussed. Case examples are included to highlight how the severity of liver disease, medication protocols, and the resulting cognitive impairment may impact an individual's disposition at the time of discharge from the acute rehabilitation setting. Therapy techniques, approaches, and compensatory strategies addressed in the acute rehabilitation environment identified and explained.

Become a SIG Affiliate
Pay Per View
Entire SIG 2 Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders content & archive
24-hour access
This Issue
24-hour access
This Article
24-hour access
We've Changed Our Publication Model...
The 19 individual SIG Perspectives publications have been relaunched as the new, all-in-one Perspectives of the ASHA Special Interest Groups.